AR111911A2 - IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS - Google Patents

IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Info

Publication number
AR111911A2
AR111911A2 ARP180101458A ARP180101458A AR111911A2 AR 111911 A2 AR111911 A2 AR 111911A2 AR P180101458 A ARP180101458 A AR P180101458A AR P180101458 A ARP180101458 A AR P180101458A AR 111911 A2 AR111911 A2 AR 111911A2
Authority
AR
Argentina
Prior art keywords
formulation
vaccine composition
adjuster
procedure
methods
Prior art date
Application number
ARP180101458A
Other languages
Spanish (es)
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of AR111911A2 publication Critical patent/AR111911A2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicación 1: Una composición de vacuna que comprende un componente de antígeno y una formulación de adyuvante, comprendiendo la formulación de adyuvante una saponina triterpenoide, un esterol, un compuesto de amonio cuaternario y un polímero de ácido poliacrílico, en donde el componente de antígeno comprende Virus de leucemia felina. Reivindicación 3: La composición de vacuna de la reivindicación 1, en la que la saponina es Quil A o una fracción purificada de la misma, el esterol es colesterol, y el compuesto de amonio cuaternario es DDA.Claim 1: A vaccine composition comprising an antigen component and an adjuvant formulation, the adjuvant formulation comprising a triterpenoid saponin, a sterol, a quaternary ammonium compound and a polyacrylic acid polymer, wherein the antigen component comprises Feline Leukemia Virus Claim 3: The vaccine composition of claim 1, wherein the saponin is Quil A or a purified fraction thereof, the sterol is cholesterol, and the quaternary ammonium compound is DDA.

ARP180101458A 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS AR111911A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7623208P 2008-06-27 2008-06-27

Publications (1)

Publication Number Publication Date
AR111911A2 true AR111911A2 (en) 2019-08-28

Family

ID=52297695

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP180101457A AR111910A2 (en) 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS
ARP180101458A AR111911A2 (en) 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP180101457A AR111910A2 (en) 2008-06-27 2018-05-31 IMMUNOGENIC COMPOSITION THAT INCLUDES AN ADJUSTER FORMULATION, VACCINE COMPOSITION, PROCEDURE, USES, METHODS

Country Status (2)

Country Link
AR (2) AR111910A2 (en)
UA (1) UA104138C2 (en)

Also Published As

Publication number Publication date
UA104138C2 (en) 2014-01-10
AR111910A2 (en) 2019-08-28

Similar Documents

Publication Publication Date Title
CL2010001360A1 (en) Immunogenic composition comprising an antigen component and an adjuvant formulation which comprises a saponin, a sterol, a quaternary ammonium compound and a polymer; preparation procedure; and its uses
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
CY1115751T1 (en) PHARMACEUTICAL COMBINATION 3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL) -PHENOLIS AND AN ANTIPEXIL
BR112015015031A2 (en) glycoconjugation process
AR036039A1 (en) VACCINE COMPOSITION FOR THE INFLUENZA VIRUS
PE20061300A1 (en) MULTIVALENT IMMUNOGENIC COMPOSITIONS INCLUDING AN ANTIGEN OF THE FLU OR ANTIGENIC PREPARATION IN COMBINATION WITH AN ADJUVANT OF EMULSION OF OIL IN WATER
EP2589392A3 (en) Process for stabilizing an adjuvant containing vaccine composition
NO20084368L (en) Stable emulsion formulations
DE602005025342D1 (en) VACCINE COMPOSITIONS WITH VIRUSOMES AND A SAPONIN ADJUVANS
EA200701632A1 (en) VACCINE AGAINST WIND SPRAY VIRUS
PE20080748A1 (en) VACCINE BASED ON THE NEISSERIA STRAINS
GB201101665D0 (en) Immunogenic compositions
WO2007124479A3 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
CL2018002692A1 (en) Bivalent vaccine against swine flu virus (divisional application 201701961)
AR067087A1 (en) VACCINE COMPOSITION AND METHOD TO PREPARE IT
BR112015005056A2 (en) combination vaccines with meningococcus serogroup b and d / t / p
ECSP109984A (en) IMPROVED PHARMACEUTICAL COMPOSITION CONTAINING DIHYDROPIRIDINE, ANTAGONIST OF THE CALCIUM CHANNEL AND THE METHOD FOR PREPARATION
BRPI0907789A2 (en) 16-alpha and 17-alpha derivatives of glucocorticosteroids and their uses
BR112012032185A2 (en) antibodies useful in passive immunization of influenza.
NO20070746L (en) Use of phosphated alkanols as dispersants, emulsifiers, hydrotropes, wetting agents and compatibility agents in agricultural compositions.
CO2019000214A2 (en) Vaccine against infectious bronchitis virus
CO6300963A2 (en) A VACCINE AGAINST THE MALARIA UNDERSTANDING P. FALCIPARUM AND P. VIVAX
BR112017012220A2 (en) processes for preparing an antigen composition and a vaccine, antigen composition, vaccine, uses of an antigen composition and a vaccine, and method for preventing or reducing infection with a swine virus and signs associated with the disease.
BR112012014689A2 (en) vaccine composition

Legal Events

Date Code Title Description
FG Grant, registration